Genmab As Stock Price History

Below is the normalized historical share price chart for Genmab AS extending back to June 01, 2009. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Genmab AS stands at 23.20, as last reported on the 12th of November 2024, with the highest price reaching 23.47 and the lowest price hitting 22.95 during the day. If you're considering investing in Genmab Stock, it is important to understand the factors that can impact its price. Genmab AS holds Efficiency (Sharpe) Ratio of -0.15, which attests that the entity had a -0.15% return per unit of risk over the last 3 months. Genmab AS exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Genmab AS's Risk Adjusted Performance of (0.09), standard deviation of 1.44, and Market Risk Adjusted Performance of (0.79) to validate the risk estimate we provide. At present, Genmab AS's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 37.1 B, whereas Common Stock Total Equity is forecasted to decline to about 52.4 M. . At present, Genmab AS's Price Book Value Ratio is projected to slightly decrease based on the last few years of reporting. The current year's Price To Operating Cash Flows Ratio is expected to grow to 27.21, whereas Price To Sales Ratio is forecasted to decline to 8.10. Genmab Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1489

Best Portfolio	Best Equity
Good Returns
Average Returns
Small Returns
Cash	Small Risk	Average Risk	High Risk	Huge Risk
Negative Returns		GMAB

Estimated Market Risk

Expected Return

Risk-Adjusted Return